MENU
+Compare
NKTR
Stock ticker: NASDAQ
AS OF
Apr 24, 10:59 AM (EDT)
Price
$0.72
Change
+$0.03 (+4.35%)
Capitalization
123.57M

NKTR Nektar Therapeutics Forecast, Technical & Fundamental Analysis

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy... Show more

Industry: #Biotechnology
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NKTR with price predictions
Apr 23, 2025

NKTR in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 27, 2025

NKTR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where NKTR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NKTR's RSI Indicator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on NKTR as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NKTR just turned positive on April 15, 2025. Looking at past instances where NKTR's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NKTR advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

NKTR moved below its 50-day moving average on March 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NKTR crossed bearishly below the 50-day moving average on March 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NKTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NKTR entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.101) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.433) is also within normal values, averaging (252.992).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NKTR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NKTR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NKTR is expected to report earnings to fall 648.67% to -16 cents per share on May 08

Nektar Therapeutics NKTR Stock Earnings Reports
Q1'25
Est.
$-0.16
Q4'24
Beat
by $0.19
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.04
The last earnings report on March 12 showed earnings per share of 2 cents, beating the estimate of -15 cents. With 249.14K shares outstanding, the current market capitalization sits at 123.57M.
A.I. Advisor
published General Information

General Information

a developer of inhalation drug delivery systems

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EUGDX26.87N/A
N/A
Morgan Stanley Europe Opportunity I
ABVAX15.88N/A
N/A
AB Large Cap Value A
SDIVX19.04N/A
N/A
Stock Dividend
CFXRX13.35N/A
N/A
Columbia Flexible Capital Income Inst2
PFPWX47.78N/A
N/A
Parnassus Value Equity Institutional

NKTR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with IPSC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+3.28%
IPSC - NKTR
47%
Loosely correlated
N/A
DNLI - NKTR
45%
Loosely correlated
+1.85%
RXRX - NKTR
44%
Loosely correlated
-0.89%
CRNX - NKTR
44%
Loosely correlated
+3.55%
ARWR - NKTR
43%
Loosely correlated
+5.26%
More